The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Molecular characterization of a peripheral receptor for cannabinoids
Abstract
The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Munro et al, 1993
In the citing paper
“CB1 and CB2 receptors exhibit disparate anatomical distributions.3”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [3]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,189
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
Seed, B. (1987) · Nature · doi:10.1038/329840a0 · Cited by 674
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 659
ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM
Simmons, D., Makgoba, M. W., & Seed, B. (1988) · Nature · doi:10.1038/331624a0 · Cited by 616
Flagged first, then by citations
Research works printed but not linked: 8
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Reichman, M., Nen, W. & Hokin, L. E. Molec. Pharmac. 40, 547–555 (1991).
- Munson, A. E. & Fehr, K. O. in Adverse Health and Behavioral Consequences of Cannabis Use (eds Fehr, K. O. & Kalant H.) 257–353 (Addiction Research Foundation, Toronto, 1983).
- Robinson, A. P., White, T. M. & Mason, D. W. Immunology 57, 239–247 (1986).
Cited by
Sorted by citations
Items 601–700 of 1,038
Wang, H., Matsumoto, H., Guo, Y. X., Paria, B. C., Roberts, R. L., & Dey, S. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436379100 · Cited by 152
Morisset, V., & Urbán, L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.40 · Cited by 152
Hebert-Chatelain, E., Reguero, L., Puente, N., Lutz, B., Chaouloff, F., Rossignol, R., Piazza, P.-V., Benard, G., Grandes, P., & Marsicano, G. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.007 · Cited by 151
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
López, A., Aparicio, N., Pazos, M. R., Grande, M. T., Barreda-Manso, M. A., Benito‐Cuesta, I., Vázquez, C., Amores, M., Ruiz‐Pérez, G., García-García, E., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1174-9 · Cited by 151
Mechanism of the Hypotensive Action of Anandamide in Anesthetized Rats
Varga, K., Lake, K. D., Huangfu, D., Guyenet, P. G., & Kunos, G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.682 · Cited by 151
Cannabinoid receptors and reward in the rat: a conditioned place preference study
Cheer, J. F., Kendall, D. A., & Marsden, C. A. (2000) · Psychopharmacology · doi:10.1007/s002130000481 · Cited by 151
Habayeb, O. M. H., Taylor, A. H., Evans, M. D., Cooke, M. S., Taylor, D. J., Bell, S. C., & Konje, J. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0681 · Cited by 151
Price, T. J., Patwardhan, A. M., Akopian, A. N., Hargreaves, K., & Flores, C. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705711 · Cited by 151
Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease
Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217877 · Cited by 150
Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
Tanaka, M., Sackett, S., & Zhang, Y. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00087 · Cited by 151
Sex differences and the endocannabinoid system in pain
Blanton, H. L., Barnes, R. C., McHann, M. C., Bilbrey, J. A., Wilkerson, J. L., & Guindon, J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173107 · Cited by 151
Romero, J., García‐Palomero, E., Castro, J. G., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00277-x · Cited by 150
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Pava, M. J., & Woodward, J. J. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.01.002 · Cited by 148
Riebe, C. J. N., & Wotjak, C. T. (2011) · Stress · doi:10.3109/10253890.2011.586753 · Cited by 149
Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 155
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
Li, Y., & Kim, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.041 · Cited by 148
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
More, S. V., & Choi, D. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0012-0 · Cited by 148
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
Wagner, J. A., Hu, K., Bauersachs, J. K., Karcher, J. C., Wiesler, M., Goparaju, S. K., Kunos, G., & Ertl, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01671-0 · Cited by 148
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00952-1 · Cited by 149
Liu, Q.-R., Canseco-Alba, A., Zhang, H.-Y., Tagliaferro, P., Chung, M., Dennis, E., Sanabria, B., Schanz, N., Escosteguy-Neto, J. C., Ishiguro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17796-y · Cited by 147
Activated microglia in the spinal cord underlies diabetic neuropathic pain
Wang, D., Couture, R., & Hong, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.057 · Cited by 148
Cannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 147
Anti‐tumour actions of cannabinoids
Hinz, B., & Ramer, R. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14426 · Cited by 148
Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 148
Schlicker, E., Timm, J., Zentner, J., & Göthert, M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005093 · Cited by 147
Rahn, E. J., Makriyannis, A., & Hohmann, A. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707333 · Cited by 146
The Enhancement of Morphine Antinociception in Mice by Î9-Tetrahydrocannabinol
Smith, F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00012-4 · Cited by 146
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 146
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Khajehali, E., Malone, D. T., Glass, M., Sexton, P. M., Christopoulos, A., & Leach, K. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099192 · Cited by 146
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 146
Functional CB2 type cannabinoid receptors at CNS synapses
Morgan, N. H., Stanford, I. M., & Woodhall, G. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.017 · Cited by 146
Association of marijuana use and the incidence of testicular germ cell tumors
Daling, J. R., Doody, D. R., Sun, X., Trabert, B. L., Weiss, N. S., Chen, C., Biggs, M. L., Starr, J. R., Dey, S. K., & Schwartz, S. M. (2009) · Cancer · doi:10.1002/cncr.24159 · Cited by 147
Shen, M., & Thayer, S. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01195-5 · Cited by 146
Piscitelli, F., Carta, G., Bisogno, T., Murru, E., Cordeddu, L., Berge, K., Tandy, S., Cohn, J. S., Griinari, M., Banni, S., et al. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-51 · Cited by 145
The emergence and analysis of synthetic cannabinoids
Hudson, S. C., & Ramsey, J. M. (2011) · Drug Testing and Analysis · doi:10.1002/dta.268 · Cited by 145
Prenatal cannabis exposure - The “first hit” to the endocannabinoid system
Richardson, K. A., Hester, A. K., & McLemore, G. L. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.08.003 · Cited by 145
Tan, L., Yan, W., McCorvy, J. D., & Cheng, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00435 · Cited by 145
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis
Mechoulam, R., & Ben‐Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 145
Lunn, C. A., Fine, J. S., Rojas-Triana, A., Jackson, J. V., Fan, X., Kung, T. T., Gonsiorek, W., Schwarz, M. A., Lavey, B. J., Kozlowski, J. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093500 · Cited by 145
The Endocannabinoid Signaling System in the CNS
Hillard, C. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 144
New Insights in Cannabinoid Receptor Structure and Signaling
Ye, L., Cao, Z., Wang, W., & Zhou, N. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190215112036 · Cited by 144
Mathison, R., Ho, W., Pittman, Q. J., Davison, J. S., & Sharkey, K. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705889 · Cited by 144
Evidence that anandamide‐signaling regulates human sperm functions required for fertilization
Schuel, H., Burkman, L. J., Lippes, J., Crickard, K., Mahony, M. C., Giuffrida, A., Picone, R. P., & Makriyannis, A. (2002) · Molecular Reproduction and Development · doi:10.1002/mrd.90021 · Cited by 144
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat
Price, T. J., Helesic, G., Parghi, D., Hargreaves, K., & Flores, C. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00333-6 · Cited by 144
McKallip, R. J., Lombard, C., Martin, B. R., Nagarkatti, M., & Nagarkatti, P. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033506 · Cited by 143
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J., & Chen, C. (2014) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 143
In vitro phase I metabolism of the synthetic cannabimimetic JWH-018
Wintermeyer, A., Möller, I., Thevis, M., Jübner, M., Beike, J., Rothschild, M. A., & Mercer‐Chalmers‐Bender, K. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4171-0 · Cited by 143
Lafenêtre, P., Chaouloff, F., & Marsicano, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.006 · Cited by 143
Cannabinoids in pancreatic cancer: Correlation with survival and pain
Michalski, C. W., Oti, F. E., Erkan, M., Sauliunaite, D., Bergmann, F., Pacher, P., Bátkai, S., Müller, M. W., Giese, N. A., Frieß, H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23114 · Cited by 143
Ceramide: a new second messenger of cannabinoid action
Guzmán, M., Galve‐Roperh, I., & Sánchez, C. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01586-8 · Cited by 143
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.006 · Cited by 142
Normandin, M. D., Zheng, M., Lin, K., Mason, N. S., Lin, S.-F., Ropchan, J. R., Labaree, D. C., Henry, S. E., Williams, W. A., Carson, R. E., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.46 · Cited by 145
Schalk‐Hihi, C., Schubert, C., Alexander, R., Bayoumy, S. S., Clemente, J. C., Deckman, I. C., DesJarlais, R. L., Dzordzorme, K. C., Flores, C. M., Grasberger, B. L., et al. (2011) · Protein Science · doi:10.1002/pro.596 · Cited by 142
Lin, S., Khanolkar, A. D., Fan, P., Goutopoulos, A., Qin, C., Papahadjis, D., & Makriyannis, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970257g · Cited by 142
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
Akopian, A. N., Ruparel, N. B., Patwardhan, A. M., & Hargreaves, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1565-06.2008 · Cited by 142
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron‐Smith, D., & Wittert, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.038 · Cited by 142
Anandamide modulates sleep and memory in rats
Murillo‐Rodríguez, E., Sánchez-Alavez, M., Navarro, L., Martínez-González, D., Drucker-Colín, R., & Prospero-Garcia, O. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00969-x · Cited by 142
Paria, B. C., Deutsch, D. D., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199610)45:2 · Cited by 142
Frost, J. M., Dart, M. J., Tietje, K. R., Garrison, T. R., Grayson, G. K., Daza, A. V., El-Kouhen, O. F., Yao, B. B., Hsieh, G. C., Pai, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901214q · Cited by 141
CB2 cannabinoid receptors promote mouse neural stem cell proliferation
Molina‐Holgado, F., Rubio‐Araiz, A., García‐Ovejero, D., Williams, R. J., Moore, J. D., Arévalo‐Martín, Á., Gómez, O., & Molina‐Holgado, E. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05322.x · Cited by 141
Chiurchiù, V., van der Stelt, M., Centonze, D., & Maccarrone, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.007 · Cited by 140
Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance
González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 140
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 140
Endocannabinoids in nervous system health and disease: the big picture in a nutshell
Skaper, S. D., & Marzo, V. D. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0313 · Cited by 141
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
Almogi‐Hazan, O., & Or, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124448 · Cited by 142
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins
Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., Simone, C. D., Rapino, C., Finazzi‐Agrò, A., & Maccarrone, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.004 · Cited by 140
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans
Ishiguro, H., Iwasaki, S., Teasenfitz, L., Higuchi, S., Horiuchi, Y., Saito, T., Arinami, T., & Onaivi, E. S. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500431 · Cited by 140
Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., Wensink, E. J., Zhan, C., Carroll, W. A., Dart, M. J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01046.x · Cited by 139
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 139
Endocannabinoid system: Role in depression, reward and pain control (Review)
Huang, W., Chen, W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5585 · Cited by 139
Maejima, T., Ohno‐Shosaku, T., & Kano, M. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00241-3 · Cited by 139
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 139
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 139
Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 139
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
Samson, M.-T., Small-Howard, A. L., Shimoda, L. M. N., Koblan‐Huberson, M., Stokes, A. J., & Turner, H. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4953 · Cited by 139
Eggerickx, D., Denef, J. F., Labbé, O., Hayashi, Y., Refetoff, S., Vassart, G., Parmentier, M., & Libert, F. (1995) · Biochemical Journal · doi:10.1042/bj3090837 · Cited by 139
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138
Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H., & Mechoulam, R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01295-0 · Cited by 138
Targeting cannabinoid receptor CB2in cardiovascular disorders: promises and controversies
Steffens, S., & Pacher, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02042.x · Cited by 137
Kaplan, B. L. F., Springs, A. E. B., & Kaminski, N. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.022 · Cited by 138
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angelidi, A. M., Belanger, M. J., Kokkinos, A. D., Koliaki, C. C., & Mantzoros, C. S. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 141
García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01625.x · Cited by 137
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 137
Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.006 · Cited by 136
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 136
Study of cannabinoid dependence in animals
Maldonado, R. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00254-1 · Cited by 136
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
Carlo, G. D., & Izzo, A. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.39 · Cited by 136
Snider, N. T., Walker, V. J., & Hollenberg, P. F. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.001081 · Cited by 136
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Alves, P., Amaral, C., Teixeira, N., & Correia-da-Silva, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104822 · Cited by 135
Bouchard, J. J., Truong, J. K., Bouchard, K. E., Dunkelberger, D. L., Desrayaud, S., Moussaoui, S. M., Tabrizi, S. J., Stella, N., & Muchowski, P. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4008-12.2012 · Cited by 135
The role of cannabinoids in adult neurogenesis
Prenderville, J. A., Kelly, A. M., & Downer, E. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13186 · Cited by 136
da Silva, K. A. B. S., Paszcuk, A. F., Passos, G. F., da Silva, E. S., Bento, A. F., Meotti, F. C., & Calixto, J. Β. (2011) · Pain · doi:10.1016/j.pain.2011.04.005 · Cited by 135
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 134
The thrifty lipids: endocannabinoids and the neural control of energy conservation
DiPatrizio, N. V., & Piomelli, D. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.006 · Cited by 135
Katsuyama, S., Mizoguchi, H., Kuwahata, H., Komatsu, T., Nagaoka, K., Nakamura, H., Bagetta, G., Sakurada, T., & Sakurada, S. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00242.x · Cited by 134
Nephrotoxic Effects of Common and Emerging Drugs of Abuse
Pendergraft, W. F., Herlitz, L., Thornley‐Brown, D., Rosner, M. H., & Niles, J. L. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00360114 · Cited by 134
Cannabinoids: Medical implications
Schrot, R. J., & Hubbard, J. R. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1145794 · Cited by 135
Metadata
- Authors
- Munro, S., Thomas, K. L., & Abu-Shaar, M.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Nature
- Published
- 1993-09
- Volume
- 365
- Issue
- 6441
- Pages
- 61-65
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2056188558
- Cited by
- 5,092
- References
- 30
- Citations by year
- 2026: 76 · 2025: 119 · 2024: 165 · 2023: 172 · 2022: 198 · 2021: 244 · 2020: 212 · 2019: 184 · 2018: 169 · 2017: 188 · 2016: 182 · 2015: 175 · 2014: 188 · 2013: 201 · 2012: 202
- FWCI
- 39.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- cannabinoid receptors, delta-9-tetrahydrocannabinol, peripheral cannabinoid receptors, macrophages, receptor cloning, G protein-coupled receptors, immunosuppression, anti-inflammatory activity
- MeSH terms
- Amides, Amino Acid Sequence, Animals, Arachidonic Acids, Base Sequence, Brain, Cannabinoids, Cloning, Molecular, DNA, Fatty Acids, Unsaturated, Humans, Macrophages, Molecular Sequence Data, Morpholines, Naphthalenes, Receptors, Drug, RNA, Spleen, Tumor Cells, Cultured, Receptors, Cannabinoid, Benzoxazines, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review